MRKR earnings

Marker Therapeutics (MRKR) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

MRKR earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 16, 2026-0.10-0.1214.29%–
Q2 2026Aug 14, 2026-0.09-0.1329.13%$700.00K
Q1 2026May 15, 2026-0.16-0.1811.11%$800.00K
Q4 2025Mar 18, 2026-0.10-0.2152.38%$1.10M
Q3 2025Nov 13, 2025-0.12-0.3666.67%$1.23M
Q2 2025Aug 14, 2025-0.29-0.304.56%$861.18K
Q1 2025May 15, 2025-0.40––$349.10K
Q4 2024Mar 31, 2025-0.42-0.22-90.91%$2.25M
Q3 2024Nov 14, 2024-0.26-0.3933.33%$1.93M
Q2 2024Aug 14, 2024-0.29-0.4332.56%$1.17M
Q1 2024May 15, 2024-0.27-0.25-8.00%$1.24M
Q3 2023Nov 9, 2023-0.34-0.9062.22%$257.61K
Q2 2023Aug 14, 2023-0.47-0.8041.25%$762.66K
Q1 2023May 16, 2023-0.570.80-171.25%$1.23M
Q3 2022Nov 10, 2022-0.80––$999.57K

Updated 2026-11-20 21:45 UTC